β2‐agonist treatment enhances uterine oxytocin receptor mRNA expression in pregnant rats

Jul 28, 2004Molecular reproduction and development

Beta 2-agonist treatment increases uterine oxytocin receptor gene activity in pregnant rats

AI simplified

Abstract

Fenoterol administration led to a maximum 125% increase in oxytocin receptor mRNA expression in the late-pregnant rat uterus.

  • Hexoprenaline induced a maximum 24% increase of oxytocin receptor mRNA.
  • Fenoterol treatment resulted in a fourfold increase in oxytocin receptor mRNA in vitro.
  • The contractility effect of oxytocin on uterine rings was significantly enhanced in fenoterol-treated rats compared to intact term pregnant rats.
  • The EC50 values for oxytocin's effect on uterine contractility were not statistically different between the groups.
  • The increase in oxytocin receptor mRNA expression induced by Beta(2)-agonists may hinder the effectiveness of these drugs in treating preterm uterine contractions.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free